Inventor

MOUSSA ADEL

US35 patents

⚠️ This page may combine multiple inventors who share the name “MOUSSA ADEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MOUSSA ADEL

ATEA PHARMACEUTICALS INC

Highly active compounds against COVID-19

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

β-D-2′-deoxy-2′-α-fluoro-2′β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatment

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

Highly active compounds against COVID-19

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

Highly active compounds against COVID-19

Highly active compounds against COVID-19

2′-substituted-N6-substituted purine nucleotides for RNA virus treatment

Highly active compounds against COVID-19

β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

2′-substituted-N6-substituted purine nucleotides for RNA virus treatment

β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections

Treatment of HCV infected patients with cirrhosis

Highly active compounds against COVID-19

Advantageous anti-HCV combination therapy

Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection

BIOTHEA PHARMA INC

Crystalline epinephrine malonate salt

Crystalline epinephrine malonate salt

Crystalline epinephrine malonate salt

IDENIX PHARMACEUTICALS INC

Process for preparing a synthetic intermediate for preparation of branched nucleosides

Substituted phenylindoles for the treatment of HIV

UTI LP

System and method for determining airspeed

Sensor placement and methods for aiding navigation during GNSS signal outage

MOUSSA ADEL

Macrocyclic serine protease inhibitors

PROFOUND POSITIONING INC

Vehicle localization system and method

NOVARTIS AG

Industrially scalable nucleoside synthesis